Market Overview

UPDATE: Sterne Agee Reiterates On Intuitive Surgical Ahead Of Advisory Committee

Share:

In a report published Wednesday, Sterne Agee analyst Gregory P. Chodaczek reiterated a Neutral rating on Intuitive Surgical (NASDAQ: ISRG), and raised the price target from $380.00 to $400.00.

In the report, Sterne Agee noted, “The FDA will convene a Medical Device Advisory Committee July 10-11 based on its previous safety advisory discouraging doctors from using power morcellators to remove fibroids. We believe this outcome will move from discouragement to an FDA requirement of a ‘boxed warning' related to the risk of cancer spread using power morcellation. Although we believe this warning will negatively affect Intuitive Surgical, we maintain our Neutral rating with a new price target of $400.00.”

Intuitive Surgical closed on Tuesday at $377.60.

Latest Ratings for ISRG

DateFirmActionFromTo
Jul 2019MaintainsBuy
May 2019MaintainsBuy
Apr 2019MaintainsBuyBuy

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Gregory P. Chodaczek Sterne AgeeAnalyst Color Price Target Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
XELMaintains60.0
SOMaintains54.0
SREMaintains141.0
EXCMaintains56.0
ESMaintains77.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Top Downgrades

The Queen Announces That Restraints On Business Will Be Cut